Automated Disulfide Bond Mapping, and Comparing Innovator and Biosimilar mAbs Using UNIFI
Applications | 2016 | WatersInstrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesPharma & Biopharma
ManufacturerWaters
Key wordsdisulfide, biosimilar, biopharmaceutical, innovator, bonds, unifi, mapping, mab, infliximab, batches, peptides, application, platform, waters, note, solution, peptide, uplc, bond, biotherapeutic, acquity, monoclonal, data, analysis, workflow, compliance, ready, mabs, scientists, containing, toolsets, linked, antibody, using, innovators, displayed, digestion, three, fit, purpose, reporting, duplicated, provides, constrained, report, organize, trending, characterization, sonicated, laboratories
Similar PDF
BIOPHARMACEUTICAL - Key Applications
2016|Waters|Guides
BIOPHARMACEUTICAL PLATFORM SOLUTION Key Applications TABLE OF CONTENTS Biopharmaceutical Platform Solution with UNIFI: Key Applications Intact Protein MS Analysis I Peptide Mapping I Released Glycan Analysis I Bioseparations Biotherapeutic proteins – such as monoclonal antibodies (mAbs), biosimilars, and antibody drug…
Key words
unifi, unifibiopharmaceutical, biopharmaceuticaluplc, uplcglycan, glycanacquity, acquityplatform, platformglycoworks, glycoworksglycans, glycanspeptide, peptidebiosimilar, biosimilaranalysis, analysissolution, solutionintact, intactinnovator, innovatorwaters
Structural Comparison of Infliximab and a Biosimilar via Subunit Analysis Using the Waters Biopharmaceutical Platform with UNIFI
2016|Waters|Applications
Structural Comparison of Infliximab and a Biosimilar via Subunit Analysis Using the Waters Biopharmaceutical Platform with UNIFI Henry Shion and Weibin Chen Waters Corporation, Milford, MA, USA A P P L I C AT I O N B E N…
Key words
infliximab, infliximabunifi, unifibiosimilar, biosimilarbiopharmaceutical, biopharmaceuticalsubunit, subunitinnovator, innovatorstructural, structuralplatform, platformcomparison, comparisonvia, viawaters, watersscientific, scientificcandidate, candidatebatches, batchesestablish
Multi-Attribute Methods for Biopharmaceutical Analysis
2022|Waters|Guides
[ APPLICATION NOTEBOOK ] Multi-Attribute Methods for Biopharmaceutical Analysis Application Notes [ APPLICATION NOTEBOOK ] Introduction The adoption of LC-MS-based multi-attribute method (MAM) analysis for routine monitoring of biotherapeutic variation has progressed greatly over the last five years. The ability…
Key words
notebook, notebookattribute, attributebiopharmaceutical, biopharmaceuticalreturn, returnmulti, multimam, mamapplication, applicationcontents, contentspeptide, peptideattributes, attributesmethods, methodsacquity, acquitymab, mabbioaccord, bioaccordmonitoring
Applying Peptide Mapping and Multi- Attribute Method (MAM) Workflow for Biosimilar mAb Drug Products Comparison on the Xevo™ G3 QTof Platform
2022|Waters|Applications
Application Note Applying Peptide Mapping and MultiAttribute Method (MAM) Workflow for Biosimilar mAb Drug Products Comparison on the Xevo™ G3 QTof Platform Kellen DeLaney, Samantha Ippoliti, Lisa Reid, Owen Cornwell, Ying Qing Yu, Emma Harry, Mark Towers Waters Corporation Abstract…
Key words
biosimilar, biosimilarmam, mamattribute, attributemapping, mappingpeptide, peptidemab, mabapplying, applyingdrug, drugworkflow, workflowmulti, multiproducts, productsmethod, methodattributes, attributesinnovator, innovatorthorough